Last Updated on June 13, 2025
The Drug Regulatory Authority of Pakistan has started compilation of Summaries of Product Characteristics (SmPC) of approved drug products. This page contains information of registered drug products which include the links for the summary of product characteristics (SmPC) and the package leaflet or patient information leaflet.
The Summary of Product Characteristics (SmPC) are living documents and provides the basis of information for the healthcare professional on how to use the drug product. This information is updated throughout the life-cycle of drug product as new data emerges. The package leaflet or patient information leaflet are also based on the SmPC information.
- Important Note:
- If a patient or his/her caregiver has any questions about a product they should contact their doctor or pharmacist. Patients should not stop taking any prescribed medicines without consulting their healthcare professionals. Suspected adverse reactions to a medicine can be reported to Pharmacovigilance Centers via our online reporting channels.
- Please note that the product information provided here reflects a copy of the Summary of Product Characteristics and outline the conditions under which the product should be used as well as information on its known safety. While efforts are being made to ensure the information accuracy, however, errors and omissions are accepted. If any inconsistency is brought to our attention, rectifications will be made immediately. The product lists are made available for information purposes only.